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ABSTRACT 
Background: The detection of celiac disease (CD) is suboptimal.  46 
Aims: We hypothesized that misdiagnosis is leading to diagnostic delays, and examine this 47 
assertion by determining if patients have increased risk of abdominal surgery before CD 48 
diagnosis. 49 
Methods: 7KURXJKELRSV\UHSRUWVIURP6ZHGHQ¶VSDWKRORJ\GHSDUWPHQWVZHLGHQWLILHGDOO50 
individuals with CD (Marsh stage 3; n=29,096). Using hospital-based data on inpatient and 51 
outpatient surgery recorded in the Swedish Patient register, we compared abdominal surgery 52 
(appendectomy, laparotomy, biliary tract surgery, and uterine surgery) with that in 144,522 53 
controls matched for age, sex, county and calendar year. Conditional logistic regression 54 
estimated odds ratios (ORs). 55 
Results: 4,064 (14.0%) individuals with CD and 15,760 (10.9%) controls had a record of earlier 56 
abdominal surgery (OR=1.36, 95%CI=1.31-1.42). Risk estimates were highest in the first year 57 
after surgery (OR=2.00; 95%CI=1.79-2.22). Appendectomy, laparotomy, biliary tract surgery, 58 
and uterine surgery were all associated with having a later CD diagnosis. Of note, abdominal 59 
surgery was also more common after CD diagnosis (hazard ratio=1.34; 95%CI=1.29-1.39) 60 
Conclusions: There is an increased risk of abdominal surgery both before and after CD 61 
diagnosis. Surgical complications associated with CD may best explain these outcomes. Medical 62 
nihilism and lack of CD awareness may be contributing to outcomes.  63 
Keywords: appendix, autoimmunity, celiac, gall bladder, inflammation, surgery 64 
 65 
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INTRODUCTION 67 
Celiac disease (CD) is an immune mediated small bowel enteropathy, which affects 1 in 100 68 
people.1, 2 It occurs in genetically susceptible individuals and is triggered by gluten, which is a 69 
protein found in wheat, barley and rye. The commonest age for diagnosis is between 40 and 60 70 
years old, however it can occur at any age, with women 1.5 to 2 times more likely to develop the 71 
condition than men.3 Diagnostic delays in CD have been widely reported, ranging between 10-13 72 
years from symptom onset to diagnosis.4-8 Recent reports from Finland, Sweden and the UK 73 
suggest these diagnostic delays are improving.4, 9, 10 This is supported by improvements in CD 74 
detection, with the ratio of clinically diagnosed CD cases to undetected cases improving in the 75 
UK from 1 in 8 in 1999 to 1 in 4 in 2011.11, 12 Although these findings are encouraging they are 76 
not universal, with data from the Canadian Celiac Health Survey showing no improvements in 77 
diagnostic delays over recent years.13    78 
 79 
These diagnostic delays can have significant consequences to patients. Individuals with CD have 80 
increased healthcare costs, higher usage rates of healthcare services and use more drugs before 81 
having a diagnosis of CD.14-16 Health related quality of life (HRQoL) can also be affected, with a 82 
recent study from Sweden showing HRQoL in undiagnosed patients to be comparable to that of 83 
stroke patients.4, 10 Delays in diagnosis may also influence morbidity, and potentiate the 84 
development of celiac-related complications 6, 17-20, however overall mortality does not appear to 85 
be influenced.21  86 
 87 
The protean clinical manifestations of CD may be responsible for the delays in diagnosis. 88 
Patients with CD can present to varying healthcare professionals, with an array of clinical 89 
symptoms and signs. These include gastrointestinal symptoms, weight loss, anaemia, reduced 90 
bone mineral density, or in association with other autoimmune diseases.1 Other individuals may 91 
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present more insidiously for example with ataxia, or peripheral neuropathy or could be 92 
asymptomatic, having been identified through screening of high-risk population groups.22 These 93 
diverse presentations create diagnostic challenges to clinicians, which could be influencing CD 94 
detection rates.  95 
 96 
Alternative reasons as to why CD detection rates remain low are that clinicians do not consider 97 
the diagnosis of CD or ignore the diagnosis (medical nihilism). Collectively, this could be 98 
termed diagnostic inertia, which is a derivation of clinical inertia where a patient fulfils the 99 
diagnostic criteria for a particular disorder, but is not diagnosed by their physician as having the 100 
disorder.23, 24 Diagnostic inertia in CD has been shown to exist in both primary and secondary 101 
care settings.7, 25 The type of clinician the patient encounters also influences diagnostic 102 
outcomes, with gastroenterologists and more experienced physicians more likely to consider and 103 
diagnose CD.6, 7, 26 Diagnostic inertia in CD has implications to patients, culminating in 104 
misdiagnosis, unnecessary interventions and potentially the prescription of inappropriate 105 
medications.5, 27  106 
 107 
These concerns lead to our hypothesis that patients with CD have higher rates of abdominal 108 
surgery before their CD diagnosis as a consequence of diagnostic inertia. Our hypothesis is 109 
tested in this large population-based study by examining abdominal surgery and the risk of 110 
having a later diagnosis of CD.  111 
 112 
MATERIALS AND METHODS 113 
Through 6ZHGHQ¶V 28 pathology departments we obtained data on CD through small intestinal 114 
biopsies with villous atrophy (Marsh III). We then used the Swedish personal identity number28 115 
to link biopsy data to surgery recorded in the Swedish Patient register.29  116 
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 117 
Exposure ± Surgery  118 
We defined abdominal surgery as either of laparotomy, appendectomy, biliary tract surgery or 119 
uterine surgery according to relevant international classification of disease (ICD) code in the 120 
Swedish Patient Register (see appendix). We did not include uterine surgery that was specifically 121 
carried out for infertility reasons, as it has been suggested that patients with CD have a decreased 122 
fertility 30, although this has been debated.31 We have previously examined CD and 123 
appendectomy 32, but that paper was restricted to individuals with an inpatient diagnosis with 124 
CD, and we have since found that risk estimates based on biopsy data on CD can be substantially 125 
different.33, 34 126 
The Swedish Patient register started in 1964. It became nationwide in 1987, adding day-surgery 127 
data in 1997, and hospital-based outpatient care in 2001. The positive predictive value of most 128 
diagnoses in this registry is between 85% and 95%.29 129 
 130 
Outcome measure - Celiac disease 131 
,7SHUVRQQHODW6ZHGHQ¶Vpathology departments identified individuals with small intestinal 132 
villous atrophy (VA; histopathology stage Marsh 3 35) from computerized biopsy reports. The 133 
data collection took place in 2006-08 but the biopsies themselves had been performed in 1969-134 
2008. Data on personal identity number, topography (duodenum and jejunum), morphology 135 
(according to SnoMed histopathology codes, for a list see our earlier publication 36), and date of 136 
biopsy were delivered to the researchers. We then reviewed the patient charts of 114 randomly 137 
selected individuals with VA and 108 (95%) had CD. The biopsy reports were based on average 138 
of three tissue specimen 37, which should, according to Pais et al, detect 95% of all CD.38 139 
Throughout the study period, biopsy was requested for CD diagnosis in Sweden. 140 
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 141 
Controls 142 
Each patient with CD was matched with up to five controls by Statistics Sweden using the 143 
Swedish Total population register.39 Matching criteria were sex, age, county, and calendar year. 144 
Removal of data irregularities and duplicates left us with 29,096 individuals with CD and 145 
144,522 matched controls, i.e. an identical data-set as in our earlier paper on mortality in CD.40  146 
 147 
Statistics 148 
We calculated odds ratios (ORs) for later CD in patients undergoing abdominal surgery using 149 
conditional logistic regression (thereby comparing strata with one CD patients and his/her 150 
matched controls). Through the conditional approach we automatically considered age, sex, 151 
county and calendar year. Of note, uterine surgery calculations were only performed in women 152 
(18,005 with CD and 89,544 controls). 153 
A priori we decided to examine the association between abdominal surgery (and its components) 154 
according to age at CD \HDUV-39 years; 40-\HDUV\HDUVVH[DQGFDOHQGDU155 
period (1997-2004; 2005-2008). We also examined the risk of CD according to time since 156 
abdominal surgery (<1, 1-DQG\HDUV In a separate analysis we adjusted for country of birth 157 
(Nordic vs. not Nordic) and education using four a priori-defined categories.41 Four percent of 158 
study participants lacked data on education and were fitted into a separate fifth category in the 159 
multivariate analysis. 160 
Finally we examined the temporal relationship between abdominal surgery and CD and used Cox 161 
regression to calculate the risk of abdominal surgery after CD. This analysis was based on 162 
individuals without a prior record of abdominal surgery at date of CD diagnosis (and 163 
corresponding date in matched controls): CD: n=25,030; controls: n=120,610. 164 
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 165 
We used SPSS 22 (SPSS, Inc. Chicago, IL, USA) for the statistics. ORs with 95% confidence 166 
intervals that did not include one were regarded as statistically significant. 167 
Ethics 168 
Our study was approved by the Ethics Review board of Stockholm, Sweden. According to the 169 
ERDUG¶VGHFLVLRQQRVWXG\SDUWLFLSDQWZDVFRQWDFWHGDVWKHVWXG\is strictly register-based.42  170 
 171 
RESULTS 172 
Background data 173 
Almost two thirds of our study participants were female (Table 1), and some 41% had received 174 
their diagnosis in childhood (Table 1). The median year of CD diagnosis (and entry year of study 175 
for the participants) was 1998 (range: 1969-2008). The median age at CD diagnosis was 30 years 176 
(range: 0-95). More than 90% of the study participants were born in the Nordic countries.  177 
 178 
 179 
Main findings 180 
Of 29,096 individuals with CD, 4,064 (14.0%) had undergone abdominal surgery prior to celiac 181 
diagnosis, compared to 15,760/144,522 (10.9%) of matched controls. This corresponded to an 182 
OR of 1.36 (95%CI=1.31-1.42). Adding level of education and country of origin to our model 183 
did not influence our risk estimates (1.35; 1.30-1.40). CD was more common in the first year 184 
after abdominal surgery (OR=2.00; 95%CI=1.79-2.22), than after 1-4 years (OR=1.31; 185 
95%CI=1.22-1.42) or after 5 years or more (OR=1.23; 95%CI=1.18-1.29). 186 
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Stratified analyses found increased risk of CD after abdominal surgery in both males and 187 
females, in all age groups and in all calendar periods although risk estimates varied (results and 188 
interaction tests are presented in Table 2). 189 
 190 
Specific conditions 191 
A laparotomy was associated with a 58% increased risk of later CD (95% CI 1.48-1.69). 192 
Similarly we found a positive association also with appendectomy (1.42; 1.34-1.50), biliary tract 193 
surgery (1.26; 1.18-1.34) and uterine surgery (1.13; 1.06-1.21) and later CD. Results of stratified 194 
analyses for the above conditions are presented in Table 3. Final diagnosis after undergoing 195 
surgery was assessed in a post-hoc analysis using relevant ICD codes, where the proportion of 196 
appendicitis, cholecystitis and uterine myoma was explored in those having inpatient 197 
appendectomy, biliary surgery and uterine surgery respectively. Restrictions were made to only 198 
inpatient diagnoses, as the Patient Register did not include both outpatient procedure codes and 199 
diagnostic codes before 2001.  For all these surgical procedures, patients with CD were less 200 
likely to have appendicitis (p=0.001), cholecystitis (p<0.001) and uterine myoma (p<0.001) at 201 
surgery than controls.  202 
 203 
Prospective analysis 204 
In order to examine the temporal relationship between abdominal surgery and CD we also 205 
carried out a Cox regression on CD and future risk of abdominal surgery. In this analysis we 206 
compared 25,030 CD patients and 120,610 matched controls without a record of abdominal 207 
surgery prior to CD diagnosis (and corresponding date in matched controls). 3536 (14.1%) of 208 
CD patients vs. 13,279 (11.0%) controls had later abdominal surgery corresponding to a Hazard 209 
ratio of 1.34 (95%CI=1.29-1.39).  210 
 211 
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DISCUSSION 212 
In this large nationwide case-control study we demonstrate that patients with CD have an 213 
increased risk of abdominal surgery both before and after diagnosis of CD, compared to sex and 214 
age-matched controls. The highest ORs for developing CD were seen just after abdominal 215 
surgery. The most plausible explanation is that abdominal surgery occurs as a complication to 216 
both undiagnosed and diagnosed CD. This notion is supported by some recent work evaluating 217 
512 CD patients where 36% of CD patients had operative interventions, of which 12% were 218 
directly for CD related problems (e.g. dysmotility, pain, malignancy).43 219 
 220 
An alternative explanation for the increased surgical rates before CD diagnosis may be 221 
misdiagnosis. Misdiagnosis is recognized and frequent in celiac patients.44 Although biliary 222 
disorders have been described in the context of CD, possibly needing surgical intervention, it is 223 
possible that the misdiagnosis of abdominal pain and iron-deficiency anaemia culminated in 224 
inappropriate abdominal surgical interventions such as appendectomy and laparotomy.45  225 
The lack of histological outcomes from the surgically removed specimens in our cohort does 226 
limit our ability to establish definitively whether misdiagnosis occurred, however the frequency 227 
of normal pathological specimens following surgical removal has previously been described, 228 
with 25.7% (64/249) of patients in a recent study having a normal appendix following 229 
appendectomy for suspected appendicitis.46 Our assessment of final diagnoses in inpatients after 230 
surgery would also support our assumptions of misdiagnosis. Review of this data permitted 231 
calculations of absolute risk differences between CD patients and controls, suggesting that 1 in 232 
24 appendectomies, 1 in 11 biliary surgeries and 1 in 16 uterine surgeries may be occurring due 233 
to unawareness of CD and its symptoms. These findings collectively support the potential of 234 
diagnostic inertia occurring in CD, contributing to identified diagnostic delays. 235 
 236 
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This study has several strengths, including its population-based design and the independent 237 
ascertainment of cases from national health registers. The Swedish National Patient Register has 238 
been validated repeatedly, and the majority of diagnoses have a high positive predictive value 239 
(85±95%).29 Furthermore, CD was identified through biopsy records showing villous atrophy. 240 
During the study period, biopsy remained the gold standard for diagnosis in both children and 241 
adults, and 6% of all pediatricians and gastroenterologists in Sweden reported performing a 242 
small intestinal biopsy before diagnosis.36 A patient chart review found that 95% of all samples 243 
with villous atrophy represented CD, a higher positive predictive value than physician-assigned 244 
diagnosis for CD in the Swedish National Patient register.47 In addition, villous atrophy in 245 
Sweden is rarely explained by diagnoses other than CD (0.3% of individuals with villous atrophy 246 
had inflammatory bowel disease).36 Although positive CD serology was not included within the 247 
definition of CD, it has been demonstrated that 88% of those with available CD serology data 248 
have positive antibodies at the time of first biopsy.36 249 
 250 
Limitations to this work are that the Swedish Patients Registry does not include individual-based 251 
data on symptoms. This means that we are unable to accurately decipher symptoms of 252 
undiagnosed CD patients at the time of a surgery, which could enhance our assertion of 253 
diagnostic inertia. A previous subset analysis of CD patients within our biopsy database suggests 254 
diarrhea (36%) and anemia (35%) are the most common clinical characteristics seen at the time 255 
of diagnosis. Given that risk of CD is highest within 1 year of abdominal surgery, it is highly 256 
likely that undiagnosed CD patients are presenting to surgical teams with µFODVVLFDO&'¶257 
symptoms.  258 
 259 
This study compares favourably to a previous study demonstrating increased surgical risk in 260 
undiagnosed CD patients (n=476).48 Our current study is significantly larger than that previous 261 
work, helping to establish high statistical precision and calculation of important subanalyses, 262 
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including stratified analyses according to sex, age and calendar period of CD diagnosis. Our 263 
work also draws comparisons to work in inflammatory bowel disease, with a recent study from 264 
&KLQDKLJKOLJKWLQJLQFUHDVHGUDWHVRIDEGRPLQDOVXUJHU\EHIRUHWKHGLDJQRVLVRI&URKQ¶V265 
disease.49  266 
 267 
As undiagnosed CD is common and misdiagnosis frequent, our findings should provide the 268 
impetus for enhanced CD testing in patients with abdominal symptoms. Previous work has 269 
suggested that undiagnosed CD patients presenting with surgical abdominal pain are being 270 
missed.50 Furthermore, this association is recognized in patients labelled with Irritable Bowel 271 
Syndrome.51 We suggest that if a patient is considered not to have acute abdominal pain 272 
warranting surgical intervention, this should alert clinicians to consider the diagnosis of CD. The 273 
use of a celiac serology is cheap and minimally invasive compared to the potential costs of 274 
surgery, which are both psychological and financial (e.g. median cholecystectomy cost = 275 
$15,651 (13,787 EUR).52 Through recognizing or questioning for celiac associated symptoms in 276 
this group of patients the detection of CD could be improved. 277 
 278 
In conclusion this is the largest study to date showing that patients with CD have increased rates 279 
of abdominal surgery both before and after CD diagnosis. Although CD is likely to be associated 280 
with surgical complications, our work emphasizes the need for clinicians to be mindful of the 281 
protean manifestations of CD. This could help improve detection, reduce unnecessary medical 282 
interventions and ease psychological burden to CD patients. 283 
 284 
 285 
286 
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